{"id":"https://openalex.org/W1970080098","doi":"https://doi.org/10.1517/13543770802553483","title":"Recent patents regarding the discovery of small molecule CXCR4antagonists","display_name":"Recent patents regarding the discovery of small molecule CXCR4antagonists","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W1970080098","doi":"https://doi.org/10.1517/13543770802553483","mag":"1970080098","pmid":"https://pubmed.ncbi.nlm.nih.gov/19441896"},"language":"en","primary_location":{"id":"doi:10.1517/13543770802553483","doi":"https://doi.org/10.1517/13543770802553483","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543770802553483","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1970080098"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079072467","display_name":"Cara A. Mosley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cara A Mosley","raw_affiliation_strings":["Department of Chemistry, Emory University, 1521 Dickey Drive, Atlanta, GA 30322, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Emory University, 1521 Dickey Drive, Atlanta, GA 30322, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055383235","display_name":"Lawrence J. Wilson","orcid":"https://orcid.org/0000-0002-6895-1051","observed_orcids":["https://orcid.org/0000-0002-6895-1051"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence J Wilson","raw_affiliation_strings":["Metastatix, 1860 Montreal Road, Tucker, GA 30054, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metastatix, 1860 Montreal Road, Tucker, GA 30054, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111562250","display_name":"John M. Wiseman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M Wiseman","raw_affiliation_strings":["Emory University, Department of Chemistry, 1521 Dickey Drive, Atlanta, GA 30322, USA +1 404 727 6602; dliotta@emory.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Department of Chemistry, 1521 Dickey Drive, Atlanta, GA 30322, USA +1 404 727 6602; dliotta@emory.edu","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064059878","display_name":"Jason W. Skudlarek","orcid":"https://orcid.org/0000-0002-5847-9144","observed_orcids":["https://orcid.org/0000-0002-5847-9144"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason W Skudlarek","raw_affiliation_strings":["Metastatix, 1860 Montreal Road, Tucker, GA 30054, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metastatix, 1860 Montreal Road, Tucker, GA 30054, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032077625","display_name":"Dennis C. Liotta","orcid":"https://orcid.org/0000-0002-7736-7113","observed_orcids":["https://orcid.org/0000-0002-7736-7113"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis C Liotta","raw_affiliation_strings":["Emory University, Department of Chemistry, 1521 Dickey Drive, Atlanta, GA 30322, USA +1 404 727 6602; dliotta@emory.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Department of Chemistry, 1521 Dickey Drive, Atlanta, GA 30322, USA +1 404 727 6602; dliotta@emory.edu","institution_ids":["https://openalex.org/I150468666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3853,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.36595547,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"19","issue":"1","first_page":"23","last_page":"38"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.8784000277519226,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.8784000277519226,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.11299999803304672,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cxcr4-antagonist","display_name":"CXCR4 antagonist","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chemokine-receptors","display_name":"chemokine receptors","score":0.871999979019165},{"id":"https://openalex.org/keywords/small-molecule-antagonists","display_name":"small molecule antagonists","score":0.6140000224113464},{"id":"https://openalex.org/keywords/peptidomimetics","display_name":"peptidomimetics","score":0.8569999933242798},{"id":"https://openalex.org/keywords/antiretroviral-drug-development","display_name":"antiretroviral drug development","score":0.7919999957084656},{"id":"https://openalex.org/keywords/host-targeted-antiviral-therapy","display_name":"host-directed antiviral therapy","score":0.6290000081062317},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.6060000061988831},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.7635851502418518},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.6494930982589722},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4604644477367401},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4021914601325989},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.34372779726982117},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32044345140457153},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2621877193450928},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13322961330413818}],"mesh":[{"descriptor_ui":"D000080027","descriptor_name":"Cyclams","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001596","descriptor_name":"Benzylamines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019718","descriptor_name":"Receptors, CXCR4","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543770802553483","doi":"https://doi.org/10.1517/13543770802553483","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543770802553483","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},{"id":"pmid:19441896","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19441896","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on therapeutic patents","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W238056528","https://openalex.org/W1500313155","https://openalex.org/W1520338063","https://openalex.org/W1526976808","https://openalex.org/W1537743144","https://openalex.org/W1548997088","https://openalex.org/W1552059218","https://openalex.org/W1561623435","https://openalex.org/W1584184882","https://openalex.org/W1584409522","https://openalex.org/W1669100117","https://openalex.org/W1723922714","https://openalex.org/W1955703696","https://openalex.org/W1966105418","https://openalex.org/W1966261980","https://openalex.org/W1967994686","https://openalex.org/W1975913849","https://openalex.org/W1979420044","https://openalex.org/W1981644527","https://openalex.org/W1996634009","https://openalex.org/W2022834758","https://openalex.org/W2027856522","https://openalex.org/W2028309086","https://openalex.org/W2049990055","https://openalex.org/W2051124223","https://openalex.org/W2064681773","https://openalex.org/W2069535635","https://openalex.org/W2077961544","https://openalex.org/W2078386562","https://openalex.org/W2082042256","https://openalex.org/W2088972966","https://openalex.org/W2097842164","https://openalex.org/W2101199324","https://openalex.org/W2105390911","https://openalex.org/W2108538162","https://openalex.org/W2112394999","https://openalex.org/W2115706633","https://openalex.org/W2124090816","https://openalex.org/W2126303695","https://openalex.org/W2135776652","https://openalex.org/W2141837666","https://openalex.org/W2144172655","https://openalex.org/W2151694552","https://openalex.org/W2154627948","https://openalex.org/W2155191802","https://openalex.org/W2156323704","https://openalex.org/W2163585811","https://openalex.org/W2165690748","https://openalex.org/W2166791241","https://openalex.org/W2169931649","https://openalex.org/W2171578213","https://openalex.org/W2263269507","https://openalex.org/W2283707433","https://openalex.org/W2344651677"],"related_works":["https://openalex.org/W2007119893","https://openalex.org/W2108538162","https://openalex.org/W2280003506","https://openalex.org/W2080845610","https://openalex.org/W2149450109","https://openalex.org/W2249685508","https://openalex.org/W2141914621","https://openalex.org/W2016627991","https://openalex.org/W2106066964","https://openalex.org/W2015278021"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,154,180,218],"chemokine":[2],"receptors,":[3],"CCR(5)":[4,52,86],"and":[5,87,159,192,237],"CXCR(4),":[6],"are":[7,172],"the":[8,58,79,91,102,124,135,142,165,203,216,233],"primary":[9],"co-receptors":[10],"responsible":[11],"for":[12,28,123,186],"mediating":[13],"HIV-1":[14],"cell":[15,45],"entry.":[16],"Small":[17],"molecules":[18],"that":[19,40,54,119,140],"antagonize":[20],"these":[21],"receptors":[22],"utilize":[23],"a":[24,73,94,114,176],"fundamentally":[25],"different":[26],"approach":[27],"controlling":[29],"viral":[30,49],"replication":[31],"than":[32,48,129],"most":[33,136],"other":[34,128],"classes":[35,139],"of":[36,81,93,104,117,126,134,149,194,205,235],"antiretroviral":[37],"agents":[38],"in":[39,57,107,145,164,215],"they":[41],"act":[42],"on":[43,223],"host":[44],"factors":[46],"rather":[47],"enzymes.":[50],"Although":[51],"modulators":[53],"demonstrate":[55],"efficacy":[56],"clinic":[59],"against":[60],"HIV":[61,82,105,187],"have":[62,202],"now":[63],"become":[64],"available,":[65],"CXCR(4)":[66,88,95,111,143,240],"antagonist":[67,96],"development":[68,92,234],"is":[69,97],"at":[70,72],"present":[71],"more":[74],"nascent":[75],"stage.":[76],"Due":[77],"to":[78,83,100,147,174,190,232],"ability":[80],"switch":[84],"between":[85],"entry":[89],"co-receptors,":[90],"probably":[98],"critical":[99],"prolonging":[101],"effectiveness":[103],"therapies":[106],"patients.":[108],"In":[109],"addition,":[110],"antagonists":[112],"represent":[113],"novel":[115],"class":[116,183],"drugs":[118],"could":[120,230],"be":[121],"used":[122],"treatment":[125,188],"diseases":[127],"HIV/AIDS.":[130],"OBJECTIVE:":[131],"An":[132],"overview":[133],"pertinent":[137],"chemical":[138],"modulate":[141],"receptor,":[144],"addition":[146],"discussions":[148],"lead":[150,231],"compound":[151],"development.":[152],"METHODS:":[153],"review":[155],"primarily":[156],"covers":[157],"patents":[158,171],"patent":[160],"application":[161],"publications":[162],"filed":[163],"past":[166],"8":[167],"years.":[168],"However,":[169],"earlier":[170],"included":[173],"provide":[175],"historical":[177],"context.":[178],"RESULTS/CONCLUSION:":[179],"early":[181],"bicyclam":[182,200],"proved":[184],"untenable":[185],"due":[189],"cardiotoxicity":[191],"lack":[193],"desirable":[195],"pharmacokinetic":[196],"properties.":[197],"Second":[198],"generation":[199],"mimics":[201],"benefit":[204],"oral":[206],"bioavailability":[207],"but":[208],"have,":[209],"as":[210],"yet,":[211],"not":[212],"proven":[213],"successful":[214],"clinic.":[217],"peptidomimetic":[219],"analogues":[220],"discussed":[221],"capitalize":[222],"known":[224],"receptor":[225],"binding":[226],"site":[227],"interactions,":[228],"which":[229],"potent":[236],"orally":[238],"available":[239],"antagonists.":[241]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1970080098","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
